143 related articles for article (PubMed ID: 12065916)
1. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock.
Bautista E; Simons FE; Simons KJ; Becker AB; Duke K; Tillett M; Kepron W; Mink SN
Int Arch Allergy Immunol; 2002 Jun; 128(2):151-64. PubMed ID: 12065916
[TBL] [Abstract][Full Text] [Related]
2. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs.
Mink SN; Simons FE; Simons KJ; Becker AB; Duke K
Clin Exp Allergy; 2004 Nov; 34(11):1776-83. PubMed ID: 15544604
[TBL] [Abstract][Full Text] [Related]
3. Effect of bolus epinephrine on systemic hemodynamics in canine anaphylactic shock.
Mink SN; Bands C; Becker A; Elkin J; Sharma S; Unruh H; Kepron W
Cardiovasc Res; 1998 Dec; 40(3):546-56. PubMed ID: 10070496
[TBL] [Abstract][Full Text] [Related]
4. Epinephrine, compared with arginine vasopressin, is associated with similar haemodynamic effects but significantly improved brain oxygenation in the early phase of anaphylactic shock in rats: An experimental study.
Zheng F; Collange O; Davidson J; Barthel G; Oulehri W; Thornton SN; Longrois D; Levy B; Audibert G; Malinovsky JM; Mertes PM
Eur J Anaesthesiol; 2015 Aug; 32(8):563-70. PubMed ID: 26244468
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and respiratory effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock.
Muelleman RL; Gatz M; Salomone JA; Herndon B; Salzman GA
Ann Emerg Med; 1989 May; 18(5):534-41. PubMed ID: 2497665
[TBL] [Abstract][Full Text] [Related]
6. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine.
Campbell RL; Bellolio MF; Knutson BD; Bellamkonda VR; Fedko MG; Nestler DM; Hess EP
J Allergy Clin Immunol Pract; 2015; 3(1):76-80. PubMed ID: 25577622
[TBL] [Abstract][Full Text] [Related]
7. 4-Aminopyridine, A Blocker of Voltage-Dependent K+ Channels, Restores Blood Pressure and Improves Survival in the Wistar Rat Model of Anaphylactic Shock.
Bellou A; Al-Hammadi S; Aburawi EH; Dhanasekaran S; Nemmar A; Oulhaj A; Shafiuallah M; Zerrouki M; Yasin J; Bellou L; Alper SL; Bellou S; Kazzam E
Crit Care Med; 2016 Nov; 44(11):e1082-e1089. PubMed ID: 27270180
[TBL] [Abstract][Full Text] [Related]
8. Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats.
Dewachter P; Jouan-Hureaux V; Lartaud I; Bello G; de Talancé N; Longrois D; Mertes PM
Anesthesiology; 2006 Apr; 104(4):734-41. PubMed ID: 16571969
[TBL] [Abstract][Full Text] [Related]
9. Endotracheal epinephrine in a canine anaphylactic shock model.
Greenberg MI; Roberts JR; Krusz JC; Baskin SI
JACEP; 1979 Dec; 8(12):500-3. PubMed ID: 513403
[TBL] [Abstract][Full Text] [Related]
10. Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model.
Rawas-Qalaji M; Rachid O; Mendez BA; Losada A; Simons FE; Simons KJ
J Pharm Pharmacol; 2015 Jan; 67(1):20-5. PubMed ID: 25256073
[TBL] [Abstract][Full Text] [Related]
11. Treatment with a platelet-activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock.
Tacquard C; Oulehri W; Collange O; Garvey LH; Nicoll S; Tuzin N; Geny B; Mertes PM
Clin Exp Allergy; 2020 Mar; 50(3):383-390. PubMed ID: 31755606
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue and epinephrine: a synergetic association for anaphylactic shock treatment.
Zheng F; Barthel G; Collange O; Montémont C; Thornton SN; Longrois D; Levy B; Audibert G; Malinovsky JM; Mertes PM
Crit Care Med; 2013 Jan; 41(1):195-204. PubMed ID: 23222265
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Evaluation of Taste-Masked Fast-Disintegrating Sublingual Tablets of Epinephrine Microcrystals.
Rachid O; Simons KJ; Rawas-Qalaji M
AAPS PharmSciTech; 2018 Nov; 19(8):3886-3894. PubMed ID: 30324360
[TBL] [Abstract][Full Text] [Related]
14. Impact of catecholamines in cardiac arrest due to acute asphyxia--a study in piglets.
Mauch J; Ringer S; Spielmann N; Weiss M
Paediatr Anaesth; 2014 Sep; 24(9):933-9. PubMed ID: 24964918
[TBL] [Abstract][Full Text] [Related]
15. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Wang M; Shibamoto T; Tanida M; Kuda Y; Kurata Y
Life Sci; 2014 Oct; 116(2):98-105. PubMed ID: 25252221
[TBL] [Abstract][Full Text] [Related]
16. Milrinone, dobutamine or epinephrine use in asphyxiated newborn pigs resuscitated with 100% oxygen.
Joynt C; Bigam DL; Charrois G; Jewell LD; Korbutt G; Cheung PY
Intensive Care Med; 2010 Jun; 36(6):1058-66. PubMed ID: 20221750
[TBL] [Abstract][Full Text] [Related]
17. Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database.
Wang T; Ma X; Xing Y; Sun S; Zhang H; Stürmer T; Wang B; Li X; Tang H; Jiao L; Zhai S
Int Arch Allergy Immunol; 2017; 173(1):51-60. PubMed ID: 28505618
[TBL] [Abstract][Full Text] [Related]
18. NButGT Reinforces the Beneficial Effects of Epinephrine on Cardiac Mitochondrial Respiration, Lactatemia and Cardiac Output in Experimental Anaphylactic Shock.
Oulehri W; Persello A; Blangy-Letheule A; Tacquard C; Rozec B; Charles AL; Geny B; Lauzier B; Mertes PM; Collange O
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542290
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
Sugiura A; Smith RA; Shatney CH
J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
[TBL] [Abstract][Full Text] [Related]
20. A hemodynamic model for anaphylactic shock.
Barsan WG; Hedges JR; Syverud SA; Dalsey WC
Ann Emerg Med; 1985 Sep; 14(9):834-9. PubMed ID: 4025979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
